Clinicopathological profile, management and clinical outcomes in recurrent cases of ocular surface squamous neoplasia at a tertiary care centre
- PMID: 35857192
- DOI: 10.1007/s10792-022-02432-0
Clinicopathological profile, management and clinical outcomes in recurrent cases of ocular surface squamous neoplasia at a tertiary care centre
Abstract
Purpose: This study was taken up to look into the various causes of recurrence, clinicopathological profile and final outcomes in recurrent cases of ocular surface squamous neoplasia (OSSN).
Methodology: A prospective cohort study was conducted and total 18 patients were recruited. All patients were subjected to detailed history, comprehensive eye examination and imaging studies. A treatment plan was formulated based on the size and extent of the lesion. The primary outcome measure was complete response to treatment with no evidence of recurrence after12 months and secondary outcome measure was complication associated with each treatment modality.
Results: The common cause of recurrence in our study was misdiagnosis of the lesion as in 15 cases it was diagnosed as pterygium and in 03 cases it was actinic keratosis. Excision Biopsy with adjunctive cryotherapy was the preferred treatment modality followed by topical interferon-alpha 2b drop-in our study. We could achieve good outcomes in terms of complete response to the treatment in 16 cases. The complication associated with this treatment was minimal in our study as few patients complained redness and irritation which subsided after application of topical lubricants. There was no sign of recurrence even at 12 months of follow-up in all 18 cases.
Conclusion: The current study provided clinicopathological characteristics and treatment outcomes in recurrent cases of OSSN. In our study, adopting appropriate treatment strategy, regular follow-up to assess the response to treatment and change over to new treatment plan in cases with inadequate response helped in achieving good outcomes in recurrent cases of OSSN.
Keywords: Excision; OSSN; Outcomes; Recurrence.
© 2022. The Author(s), under exclusive licence to Springer Nature B.V.
Similar articles
-
Long term study of topical interferon α-2b eye drops as primary treatment of ocular surface squamous neoplasia.Ocul Surf. 2023 Apr;28:108-114. doi: 10.1016/j.jtos.2022.12.009. Epub 2022 Dec 30. Ocul Surf. 2023. PMID: 36592780 Free PMC article.
-
Surgical versus medical treatment of ocular surface squamous neoplasia: a comparison of recurrences and complications.Ophthalmology. 2014 May;121(5):994-1000. doi: 10.1016/j.ophtha.2013.11.017. Epub 2014 Jan 9. Ophthalmology. 2014. PMID: 24411578 Free PMC article.
-
Role of topical interferon alpha-2b in 'mitomycin-C-resistant' ocular surface squamous neoplasia: our preliminary findings.Int Ophthalmol. 2019 Feb;39(2):295-301. doi: 10.1007/s10792-017-0811-0. Epub 2018 Jan 23. Int Ophthalmol. 2019. PMID: 29362973
-
Bilateral ocular surface squamous neoplasia: A study of 25 patients and review of literature.Eur J Ophthalmol. 2022 Jan;32(1):620-627. doi: 10.1177/11206721211007109. Epub 2021 Apr 5. Eur J Ophthalmol. 2022. PMID: 33818167 Review.
-
The Management of Ocular Surface Squamous Neoplasia (OSSN).Int J Mol Sci. 2022 Dec 31;24(1):713. doi: 10.3390/ijms24010713. Int J Mol Sci. 2022. PMID: 36614155 Free PMC article. Review.
References
-
- Lee GA, Hirst LW (1995) Ocular surface squamous neoplasia. Surv Ophthalmol 1995(39):429–450 - DOI
-
- Shield CL, Ramasubramanium A, Mellen PL, Shield JA (2011) Conjunctival squamous cell carcinoma arising in immunosuppressed patients (organ transplant, humandeficiency virus infections). Ophthalmology 118:2131–2133
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical